AstraZeneca has reported the first clinical data with its oral PCSK9 inhibitor AZD0780, which it hopes could offer an alternative to current injectable drugs used to lower cholesterol.

Chicago baseball report: Why Cubs are keeping Dansby Swanson in No. 5 spot — and Grant Taylor’s rare feat for White Sox ...